Seehra Jasbir 4
4 · Keros Therapeutics, Inc. · Filed Apr 7, 2025
Insider Transaction Report
Form 4
Seehra Jasbir
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-04-04$0.30/sh+49,367$14,810→ 302,223 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-04-04−49,367→ 252,444 totalExercise: $0.30Exp: 2028-03-25→ Common Stock (49,367 underlying)
Footnotes (1)
- [F1]Immediately exercisable.